-
Je něco špatně v tomto záznamu ?
Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials
J. Fučíková, D. Rožková, H. Ulčová, V. Budinský, K. Sochorová, K. Pokorná, J. Bartůňková, R. Špíšek,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT11559
MZ0
CEP - Centrální evidence projektů
NT12402
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Plný text - Článek
Zdroj
Zdroj
NLK
BioMedCentral
od 2003-06-01
BioMedCentral Open Access
od 2003
Directory of Open Access Journals
od 2003
Free Medical Journals
od 2003
PubMed Central
od 2003
Europe PubMed Central
od 2003
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2003-01-01
Open Access Digital Library
od 2003-07-01
Open Access Digital Library
od 2003-01-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2003
Springer Nature OA/Free Journals
od 2003-06-01
PubMed
22208910
DOI
10.1186/1479-5876-9-223
Knihovny.cz E-zdroje
- MeSH
- buněčná diferenciace účinky léků MeSH
- dendritické buňky cytologie účinky léků MeSH
- epitopy imunologie MeSH
- fenotyp MeSH
- imunoterapie metody MeSH
- klinické zkoušky jako téma MeSH
- kultivační média farmakologie MeSH
- lidé MeSH
- nádory imunologie terapie MeSH
- poly I-C farmakologie MeSH
- proliferace buněk účinky léků MeSH
- regulační T-lymfocyty cytologie účinky léků imunologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: For clinical applications, dendritic cells (DCs) need to be generated using GMP-approved reagents. In this study, we tested the characteristics of DCs generated in two clinical grade culture media and activated by three maturation stimuli, Poly I: C, LPS and the mixture of proinflammatory cytokines in order to identify the optimal combination of culture media and activation stimulus for the clinical use. METHOD: We tested DCs generation using two GMP-certified culture media, CellGro and RPMI+5% human AB serum and evaluated DCs morphology, viability and capapability to mature. We tested three maturation stimuli, PolyI:C, LPS and the mixture of proinflammatory cytokines consisting of IL-1, IL-6, TNF and prostaglandin E2. We evaluated the capacity of activated DCs to induce antigen-specific T cells and regulatory T lymphocytes. RESULTS: Cell culture in CellGro resulted in a higher yield of immature DCs resulting from increased number of adherent monocytes. DCs that were generated in CellGro and activated using Poly I:C were the most efficient in expanding antigen-specific T cells compared to the DCs that were generated in other media and activated using LPS or the cocktail of proinflammatory cytokines. A comparison of all tested combinations revealed that DCs that were generated in CellGro and activated using Poly I:C induced low numbers of regulatory T cells. CONCLUSION: In this study, we identified monocyte-derived DCs that were generated in CellGro and activated using Poly I:C as the most potent clinical-grade DCs for the induction of antigen-specific T cells.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12022445
- 003
- CZ-PrNML
- 005
- 20191015105552.0
- 007
- ta
- 008
- 120806e20111230xxk f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1186/1479-5876-9-223 $2 doi
- 035 __
- $a (PubMed)22208910
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Fučíková, Jitka, $u Department of Immunology, Charles University, Prague, Czech Republic. $d 1983- $7 xx0116819
- 245 10
- $a Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials / $c J. Fučíková, D. Rožková, H. Ulčová, V. Budinský, K. Sochorová, K. Pokorná, J. Bartůňková, R. Špíšek,
- 520 9_
- $a BACKGROUND: For clinical applications, dendritic cells (DCs) need to be generated using GMP-approved reagents. In this study, we tested the characteristics of DCs generated in two clinical grade culture media and activated by three maturation stimuli, Poly I: C, LPS and the mixture of proinflammatory cytokines in order to identify the optimal combination of culture media and activation stimulus for the clinical use. METHOD: We tested DCs generation using two GMP-certified culture media, CellGro and RPMI+5% human AB serum and evaluated DCs morphology, viability and capapability to mature. We tested three maturation stimuli, PolyI:C, LPS and the mixture of proinflammatory cytokines consisting of IL-1, IL-6, TNF and prostaglandin E2. We evaluated the capacity of activated DCs to induce antigen-specific T cells and regulatory T lymphocytes. RESULTS: Cell culture in CellGro resulted in a higher yield of immature DCs resulting from increased number of adherent monocytes. DCs that were generated in CellGro and activated using Poly I:C were the most efficient in expanding antigen-specific T cells compared to the DCs that were generated in other media and activated using LPS or the cocktail of proinflammatory cytokines. A comparison of all tested combinations revealed that DCs that were generated in CellGro and activated using Poly I:C induced low numbers of regulatory T cells. CONCLUSION: In this study, we identified monocyte-derived DCs that were generated in CellGro and activated using Poly I:C as the most potent clinical-grade DCs for the induction of antigen-specific T cells.
- 650 _2
- $a buněčná diferenciace $x účinky léků $7 D002454
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a klinické zkoušky jako téma $7 D002986
- 650 _2
- $a kultivační média $x farmakologie $7 D003470
- 650 _2
- $a dendritické buňky $x cytologie $x účinky léků $7 D003713
- 650 _2
- $a epitopy $x imunologie $7 D000939
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunoterapie $x metody $7 D007167
- 650 _2
- $a nádory $x imunologie $x terapie $7 D009369
- 650 _2
- $a fenotyp $7 D010641
- 650 _2
- $a poly I-C $x farmakologie $7 D011070
- 650 _2
- $a regulační T-lymfocyty $x cytologie $x účinky léků $x imunologie $7 D050378
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Rožková, Daniela, $d 1979- $7 xx0118296
- 700 1_
- $a Ulčová, Hana, $d 1981- $7 xx0118298
- 700 1_
- $a Budinský, Vít, $d 1980- $7 xx0118293
- 700 1_
- $a Sochorová, Klára, $d 1981- $7 xx0092234
- 700 1_
- $a Pokorná, Kateřina $7 xx0140490
- 700 1_
- $a Bartůňková, Jiřina, $d 1958- $7 jn20000400093
- 700 1_
- $a Špíšek, Radek, $d 1975- $7 nlk20030145288
- 773 0_
- $w MED00008239 $t Journal of translational medicine $x 1479-5876 $g Roč. 9(20111230), s. 223
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22208910 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120806 $b ABA008
- 991 __
- $a 20191015110017 $b ABA008
- 999 __
- $a ok $b bmc $g 944358 $s 779742
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 9 $d 223 $e 20111230 $i 1479-5876 $m Journal of translational medicine $n J Transl Med $x MED00008239
- GRA __
- $a NT11559 $p MZ0
- GRA __
- $a NT12402 $p MZ0
- LZP __
- $a Pubmed-20120806/12/01